• xantoxis@lemmy.world
    link
    fedilink
    arrow-up
    14
    arrow-down
    1
    ·
    edit-2
    1 year ago

    I suspect the correct market price, if it is sold on a market basis at all, should be somewhere between $12 and $32. “Manufacturing cost” is usually the cost to produce a packaged dose in the machine. It includes raw materials, power, labor involved. It doesn’t include QA, shipping, standards compliance, accounting, and so on. These things are necessary no matter how the drug is produced, and no matter by whom it is produced; but they aren’t “manufacturing cost” in the strictest sense. They would factor into market price.

    But here are some other things “manufacturing cost” doesn’t include: marketing, sales, profit margin, and the cost of price collusion. These things are the reasons insulin shouldn’t be sold on a market basis at all, and as such, should be free (as in price). Healthcare as a whole suffers from these problems. Insulin is just a particularly-obvious indicator of the whole con.

    • rjs001@lemmygrad.ml
      link
      fedilink
      arrow-up
      8
      arrow-down
      1
      ·
      1 year ago

      Oh I agree with you but my mention was that Sanders was acting like $32 was at all acceptable

      • xantoxis@lemmy.world
        link
        fedilink
        arrow-up
        8
        ·
        1 year ago

        Yes, we’re definitely agreeing. Sanders is being pragmatic in this instance, but we as a society should go farther.